The true cost of bone marrow transplantation

Frederick M. Weeks, Gary C Yee, Alison A. Bartfield, John R. Wingard

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies. Bone marrow transplantation is much more costly 'up-front' but perhaps not more costly long-term than alternative therapies. Although economic analyses appear relatively simple, interpretation and use can be problematic. Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy. Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more affectively control these complications. The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment- related mortality, and costs. More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.

Original languageEnglish (US)
Pages (from-to)101-112
Number of pages12
JournalAmerican Journal of the Medical Sciences
Volume314
Issue number2
DOIs
StatePublished - Jan 1 1997

Fingerprint

Bone Marrow Transplantation
Costs and Cost Analysis
Economics
Ambulatory Care
Complementary Therapies
Health Care Costs
Patient Selection
Cost-Benefit Analysis
Length of Stay
Therapeutics
Bone Marrow
Technology
Transplants
Drug Therapy
Mortality
Neoplasms

Keywords

  • Bone marrow transplantation
  • Cost
  • Cost-effectiveness
  • High-dose chemotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The true cost of bone marrow transplantation. / Weeks, Frederick M.; Yee, Gary C; Bartfield, Alison A.; Wingard, John R.

In: American Journal of the Medical Sciences, Vol. 314, No. 2, 01.01.1997, p. 101-112.

Research output: Contribution to journalReview article

Weeks, Frederick M. ; Yee, Gary C ; Bartfield, Alison A. ; Wingard, John R. / The true cost of bone marrow transplantation. In: American Journal of the Medical Sciences. 1997 ; Vol. 314, No. 2. pp. 101-112.
@article{95ae48639516466cb9d85ec968eb2edf,
title = "The true cost of bone marrow transplantation",
abstract = "Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies. Bone marrow transplantation is much more costly 'up-front' but perhaps not more costly long-term than alternative therapies. Although economic analyses appear relatively simple, interpretation and use can be problematic. Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy. Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more affectively control these complications. The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment- related mortality, and costs. More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.",
keywords = "Bone marrow transplantation, Cost, Cost-effectiveness, High-dose chemotherapy",
author = "Weeks, {Frederick M.} and Yee, {Gary C} and Bartfield, {Alison A.} and Wingard, {John R.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1097/00000441-199708000-00012",
language = "English (US)",
volume = "314",
pages = "101--112",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The true cost of bone marrow transplantation

AU - Weeks, Frederick M.

AU - Yee, Gary C

AU - Bartfield, Alison A.

AU - Wingard, John R.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies. Bone marrow transplantation is much more costly 'up-front' but perhaps not more costly long-term than alternative therapies. Although economic analyses appear relatively simple, interpretation and use can be problematic. Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy. Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more affectively control these complications. The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment- related mortality, and costs. More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.

AB - Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies. Bone marrow transplantation is much more costly 'up-front' but perhaps not more costly long-term than alternative therapies. Although economic analyses appear relatively simple, interpretation and use can be problematic. Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy. Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more affectively control these complications. The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment- related mortality, and costs. More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.

KW - Bone marrow transplantation

KW - Cost

KW - Cost-effectiveness

KW - High-dose chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0030738672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030738672&partnerID=8YFLogxK

U2 - 10.1097/00000441-199708000-00012

DO - 10.1097/00000441-199708000-00012

M3 - Review article

VL - 314

SP - 101

EP - 112

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 2

ER -